Clinical Trial Update: Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT) [Phase 3]

View source ↗

Summary

This is a Phase 3 trial evaluating neoadjuvant toripalimab plus chemotherapy with or without cetuximab for locally advanced head and neck squamous cell carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 3 | Status: NOT_YET_RECRUITING